{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:35:50Z","timestamp":1790793350607,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"ISF College of Pharmacy"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.neuro.2014.05.009","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T14:56:13Z","timestamp":1401720973000},"page":"71-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats"],"prefix":"10.1016","volume":"44","author":[{"given":"Rohit","family":"Bisht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baninder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atish","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2014.05.009_bib0005","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0891988710383572","article-title":"The genetics of Parkinson disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.parkreldis.2004.02.011","article-title":"Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms","volume":"10","author":"Blanchet","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.05.009_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.parkreldis.2011.02.013","article-title":"Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review","volume":"17","author":"Broen","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuro.2014.05.009_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.STR.0000252091.36912.65","article-title":"Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation","volume":"38","author":"Chu","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neuro.2014.05.009_bib0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cne.21852","article-title":"Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats","volume":"511","author":"Chung","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0035","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.bjp.0702673","article-title":"Comparison of the functional potencies of Ropinirolee and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells","volume":"127","author":"Coldwell","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0040","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10072-013-1585-4","article-title":"Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury","volume":"35","author":"Cui","year":"2014","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0050","doi-asserted-by":"crossref","first-page":"16691","DOI":"10.1073\/pnas.1006083107","article-title":"Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function","volume":"107","author":"Dawson","year":"2010","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.neuro.2014.05.009_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-8-7","article-title":"Reduced spiral ganglion neuronal loss by adjunctive neurotrophin-3 in experimental pneumococcal meningitis","volume":"8","author":"Demel","year":"2011","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.neuro.2014.05.009_bib0065","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuro.2014.05.009_bib0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/ars.2009.2444","article-title":"Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis","volume":"11","author":"Foran","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.neuro.2014.05.009_bib0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0091-3057(99)00240-3","article-title":"Effects of Ropinirolee on various parkinsonian models in mice, rats, and cynomolgus monkeys","volume":"65","author":"Fukuzaki","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2014.05.009_bib0085","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","article-title":"Determination of serum proteins by means of the biuret reaction","volume":"177","author":"Gornall","year":"1949","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.05.009_bib0090","first-page":"265","article-title":"Analysis of nitrate, nitrite and (15N) nitrate in biological fluids","volume":"193","author":"Green","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.05.009_bib0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0896-6273(00)80798-9","article-title":"Beyond the dopamine receptor: the DARPP-32\/protein phosphatase-1 cascade","volume":"23","author":"Greengard","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuro.2014.05.009_bib0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-007-9463-1","article-title":"Glutamate uptake is reduced in prefrontal cortex in Huntington's disease","volume":"33","author":"Hassel","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuro.2014.05.009_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2013.03.018","article-title":"Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model","volume":"242","author":"Inui","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.05.009_bib0110","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-2236(89)90007-6","article-title":"Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease","volume":"12","author":"Klockgether","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","article-title":"Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking","volume":"67","author":"Knackstedt","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuro.2014.05.009_bib0125","series-title":"Practical Pharmacology and Clinical Pharmacy","first-page":"136","author":"Kulkarni","year":"2008"},{"key":"10.1016\/j.neuro.2014.05.009_bib0130","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1476-5381.2011.01418.x","article-title":"Role of LOX\/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone","volume":"164","author":"Kumar","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","article-title":"Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity","volume":"674","author":"Kumar","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0140","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1074\/jbc.M707697200","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes","volume":"283","author":"Lee","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuro.2014.05.009_bib0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0150","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","article-title":"Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps","volume":"14","author":"Levy","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.neuro.2014.05.009_bib0155","first-page":"301","article-title":"Clinical rehabilitation effect of Ropinirole on cognitive and motor disorders in patients with Parkinson's disease","volume":"91","author":"Li","year":"2011","journal-title":"Zhonqhua Yi Xue Za Zhi"},{"key":"10.1016\/j.neuro.2014.05.009_bib0160","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuroscience.2007.02.003","article-title":"Neuroprotective potential of ceftriaxone in in vitro models of stroke","volume":"146","author":"Lipski","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.05.009_bib0165","first-page":"885","article-title":"Catalase","volume":"vol. III","author":"Luck","year":"1971"},{"key":"10.1016\/j.neuro.2014.05.009_bib0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mehy.2006.01.013","article-title":"Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders","volume":"67","author":"Mccarty","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neuro.2014.05.009_bib0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jnnp-2012-303182","article-title":"Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study","volume":"84","author":"Moreau","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuro.2014.05.009_bib0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2013.01.017","article-title":"Ropinirole protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice via anti-apoptotic mechanism","volume":"104","author":"Park","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2014.05.009_bib0185","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.neuro.2014.05.009_bib0190","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2967\/jnumed.106.037796","article-title":"Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats","volume":"48","author":"Pellegrino","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neuro.2014.05.009_bib0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuro.2014.05.009_bib0200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","article-title":"Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system","volume":"90","author":"Pickering","year":"2005","journal-title":"Exp Physiol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0205","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archneurol.2010.191","article-title":"Prospects for minocycline neuroprotection","volume":"67","author":"Plane","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuro.2014.05.009_bib0215","first-page":"2046","article-title":"Parkinson's disease: diagnosis and treatment","volume":"74","author":"Rao","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.neuro.2014.05.009_bib0220","first-page":"119","article-title":"Antisense knockdown of the glial glutamate transporter GLT-1 exacerbates hippocampal neuronal damage following traumatic injury to rat brain","volume":"13","author":"Rao","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0225","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00726-010-0589-0","article-title":"Beta-lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats","volume":"40","author":"Rasmussen","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuro.2014.05.009_bib0230","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.drugalcdep.2009.10.010","article-title":"Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation","volume":"107","author":"Rawls","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuro.2014.05.009_bib0235","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jneumeth.2007.08.024","article-title":"Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease","volume":"167","author":"Reksidler","year":"2008","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuro.2014.05.009_bib0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuro.2014.05.009_bib0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2009.11.026","article-title":"Oxidative damage in Parkinson disease: measurement using accurate biomarkers","volume":"48","author":"Seet","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.neuro.2014.05.009_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4236\/pp.2013.43A001","article-title":"Ropinirole implants reverse MPTP-induced Parkinsonism in rhesus monkeys","volume":"4","author":"Siegel","year":"2013","journal-title":"Pharmacol Pharm"},{"key":"10.1016\/j.neuro.2014.05.009_bib0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuint.2007.03.012","article-title":"The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention","volume":"51","author":"Sheldon","year":"2007","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neuro.2014.05.009_bib0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152710791292648","article-title":"Clinical trials for neuroprotection in ALS","volume":"9","author":"Siciliano","year":"2010","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuro.2014.05.009_bib0265","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/toxsci\/kfr115","article-title":"Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations","volume":"122","author":"Singh","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.neuro.2014.05.009_bib0270","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0091-3057(02)00838-9","article-title":"Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats","volume":"73","author":"Veerendra Kumar","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuro.2014.05.009_bib0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2010.04.021","article-title":"Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia\/reperfusion injury","volume":"638","author":"Verma","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuro.2014.05.009_bib0280","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem J"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X14000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:16:27Z","timestamp":1758982587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X14000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":55,"alternative-id":["S0161813X14000904"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2014.05.009","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2014.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}